Pharmafile Logo
Pharmafocus logo
Advanced Search

Hyloris announces approval of new drug for pain management

October 19, 2021
Manufacturing and Production

Specialist biopharma company Hyloris has announced the further extension of the European footprint of Maxigesic® IV, which is a novel …

News

National Institutes of Health to evaluate Enesi Pharma’s Implavax®-enabled flu vaccines

October 19, 2021
Manufacturing and Production

Enesi Pharma, a pioneering biotechnology company, has entered an agreement with the US National Insitutes of Health’s (NIH) National Institute …

News

Lipocine and Antares Pharma enter agreement to commercialise TLANDO®

October 19, 2021
Manufacturing and Production

Clinical-stage biopharmaceutical company, Lipocine Inc, has announced that it has entered an exclusive licensing agreement with Antares Pharma Inc to …

News

Global Heart Hub and Novartis form partnership to combat ASCVD

October 19, 2021
Manufacturing and Production

Global Heart Hub and Novartis have announced the launch of a joint programme to bring together a worldwide network of …

News

Survey reveals efficacy of Pfizer and AstraZeneca vaccines against positive COVID-19 tests

October 18, 2021
Sales and Marketing

Data from the Coronavirus Infection Survey (CIS), and pillars 1 and 2 of the NHS Test and Trace have measured …

News

MindMaze and The Royal Buckinghamshire Hospital create brain repair platform

October 18, 2021
Sales and Marketing

MindMaze Healthcare, major leader in the multi billion-dollar digital neurotherapeutics market, has announced the first UK partnership for its MindPod™ …

News

Major trial proposes how to reduce ICU infections caused by staphylococcus aureus

October 18, 2021
Sales and Marketing

A major US hospital-based clinical trial has highlighted the benefit of using nasal decolonisation to reduce ICU infections caused by …

News

Valneva COVID-19 vaccine shown to be more effective than AstraZeneca candidate

October 18, 2021
Sales and Marketing

French biotech company, Valneva, has announced positive results from the Phase III trial of its inactivated, adjuvanted COVID-19 vaccine candidate, …

News

First Indian anti-cancer drug launches in China

October 15, 2021
Medical Communications

The first Indian anti-cancer drug, Abiraterone Acetate API, has launched in China, by Dr Reddy’s Laboratories. This breakthrough was announced …

News
moderna_norwood_plant

FDA approves emergency booster dose of Moderna’s COVID-19 vaccine

October 15, 2021
Medical Communications

The FDA Advisory Committee has unanimously voted in support of emergency use for a booster dose of Moderna’s COVID-19 vaccine …

News
astrazeneca_sign_sky

EMA begins real-time review of AstraZeneca’s COVID antibody cocktail

October 15, 2021
Medical Communications

The human medicines committee of the EMA has begun the rolling review of AstraZeneca’s antibody-based COVID-19 therapy, the first protective …

News

Abbott Labs recalls two COVID test kits after false positives

October 15, 2021
Medical Communications

A unit of Abbott Laboratories is recalling two COVID-19 lab test kits over concerns they can potentially issue false positives, …

News

Anticancer Bioscience receives additional $10.6m investment into cancer therapy

October 14, 2021
Business Services

Precision oncology company, Anticancer Bioscience (ACB),  has announced that it has secured an additional $10.6 million from Chinese investors. The …

News

Lexeo Therapeutics and FUJIFILM announce partnership to co-develop gene therapies

October 14, 2021
Business Services

LEXEO Therapeutics, clinical-stage gene therapy company, and FUJIFILM Diosynth Biotechnologies, world leading CDMO for biologics, viral vaccines and viral vectors, …

News

WHO’s new taskforce “last chance” to track COVID origins

October 14, 2021
Business Services

The WHO has put together a new taskforce, the Scientific Advisory Group on the Origins of Novel Pathogens (Sago), with …

News

UCL: Lateral flow test more accurate than previously thought

October 14, 2021
Business Services

Researchers from University College London (UCL) have been studying the accuracy of lateral flow tests (LFTs), and have found them …

News

Verona Pharma to present Phase II data with pMDI for COPD patients

October 13, 2021
Research and Development

Clinical-stage biopharmaceutical company, Verona Pharma plc (Verona), is due to present Phase II data demonstrating the positive effect of a …

News

Empagliflozin (Jardiance®) receives SMC approval for treatment of heart failure

October 13, 2021
Research and Development

The Scottish Medicines Consortium (SMC) has announced that empagliflozin (Jardiance®) has been accepted for use by NHS Scotland, for the …

News
moderna_norwood_plant

Gavi to purchase 176.5 million doses of Moderna COVID-19 vaccine for low income countries

October 13, 2021
Research and Development

COVAX has purchased more than 210 million doses of their vaccine for delivery to low income countries. This supply agreement …

News

Symbiosis Pharma to manufacture Modus’ sepsis treatment

October 12, 2021
Manufacturing and Production

Modus Therapeutics, a company developing pharmaceutical therapies for diseases with high unmet medical need, has announced that Symbiosis Pharmaceutical Services …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026